{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T12:17:55Z","timestamp":1780661875636,"version":"3.54.1"},"reference-count":77,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003593","name":"CNPq","doi-asserted-by":"publisher","award":["423165\/2021-6"],"award-info":[{"award-number":["423165\/2021-6"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"FAPESP","doi-asserted-by":"publisher","award":["2017\/04352-0"],"award-info":[{"award-number":["2017\/04352-0"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"FAPESP","doi-asserted-by":"publisher","award":["2018\/09158-0"],"award-info":[{"award-number":["2018\/09158-0"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"FAPESP","doi-asserted-by":"publisher","award":["2019\/01487-7"],"award-info":[{"award-number":["2019\/01487-7"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimie"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.biochi.2023.03.013","type":"journal-article","created":{"date-parts":[[2023,3,28]],"date-time":"2023-03-28T11:20:15Z","timestamp":1680002415000},"page":"21-30","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Expression of thimet oligopeptidase (THOP) modulated by oxidative stress in human multidrug resistant (MDR) leukemia cells"],"prefix":"10.1016","volume":"212","author":[{"given":"Raquel Le\u00e3o","family":"Neves","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alyne","family":"Marem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Carmona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00falia Galanakis","family":"Arata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcos Paulo","family":"Cyrillo Ramos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giselle Zenker","family":"Justo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabiana Henriques","family":"Machado de Melo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vitor","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0746-5279","authenticated-orcid":false,"given":"Marcelo Yudi","family":"Icimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biochi.2023.03.013_bib1","doi-asserted-by":"crossref","first-page":"339","DOI":"10.15171\/apb.2017.041","article-title":"The different mechanisms of cancer drug resistance: a brief review","volume":"7","author":"Mansoori","year":"2017","journal-title":"Adv. Pharmaceut. Bull."},{"key":"10.1016\/j.biochi.2023.03.013_bib2","doi-asserted-by":"crossref","first-page":"3233","DOI":"10.3390\/ijms21093233","article-title":"Mechanisms of multidrug resistance in cancer chemotherapy","volume":"21","author":"Bukowski","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biochi.2023.03.013_bib3","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1590\/S0001-37652001000100007","article-title":"Multidrug resistance in tumour cells: characterisation of the multidrug resistant cell line K562-Lucena 1","volume":"73","author":"Rumjanek","year":"2001","journal-title":"An Acad. Bras Ci\u00eancias"},{"key":"10.1016\/j.biochi.2023.03.013_bib4","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20130067","article-title":"Multidrug resistance in chronic myeloid leukaemia: how much can we learn from MDR\u2013CML cell lines?","volume":"33","author":"Rumjanek","year":"2013","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.biochi.2023.03.013_bib5","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1093\/jnci\/djt184","article-title":"MHC class I antigen processing and presenting machinery: organization, function, and defects in tumor cells","volume":"105","author":"Leone","year":"2013","journal-title":"JNCI J. Nat. Cancer Inst."},{"key":"10.1016\/j.biochi.2023.03.013_bib6","doi-asserted-by":"crossref","first-page":"5108","DOI":"10.1021\/acs.jmedchem.7b01457","article-title":"Inhibit or evade multidrug resistance P-glycoprotein in cancer treatment","volume":"61","author":"Waghray","year":"2018","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.biochi.2023.03.013_bib7","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1002\/med.21739","article-title":"Chemical molecular-based approach to overcome multidrug resistance in cancer by targeting P-glycoprotein (P-gp)","volume":"41","author":"Zhang","year":"2021","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.biochi.2023.03.013_bib8","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1146\/annurev.ge.29.120195.003135","article-title":"Genetic analysis of the multidrug transporter","volume":"29","author":"Gottesman","year":"1995","journal-title":"Annu. Rev. Genet."},{"key":"10.1016\/j.biochi.2023.03.013_bib9","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1042\/bse0500161","article-title":"The P-glycoprotein multidrug transporter","volume":"50","author":"Sharom","year":"2011","journal-title":"Essays Biochem."},{"key":"10.1016\/j.biochi.2023.03.013_bib10","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1146\/annurev-pharmtox-010715-103111","article-title":"Toward a better understanding of the complexity of cancer drug resistance","volume":"56","author":"Gottesman","year":"2016","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.biochi.2023.03.013_bib11","doi-asserted-by":"crossref","first-page":"9213","DOI":"10.1073\/pnas.91.20.9213","article-title":"Peptidase activities of proteasomes are differentially regulated by the major histocompatibility complex-encoded genes for LMP2 and LMP7","volume":"91","author":"Gaczynska","year":"1994","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.biochi.2023.03.013_bib12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0217940","article-title":"Prolonged inhibition of P-glycoprotein after exposure to chemotherapeutics increases cell mortality in multidrug resistant cultured cancer cells","volume":"14","author":"Nanayakkara","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.biochi.2023.03.013_bib13","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/368864a0","article-title":"MHC class l\/\u03b22-microglobulin complexes associate with TAP transporters before peptide binding","volume":"368","author":"Ortmann","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.biochi.2023.03.013_bib14","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.bmc.2016.11.023","article-title":"A\u00a0novel curcumin derivative which inhibits P-glycoprotein, arrests cell cycle and induces apoptosis in multidrug resistance cells","volume":"25","author":"Lopes-Rodrigues","year":"2017","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.biochi.2023.03.013_bib15","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1097\/MOT.0b013e32833bfb33","article-title":"Structure and function of major histocompatibility complex class I antigens","volume":"15","author":"Li","year":"2010","journal-title":"Curr. Opin. Organ Transplant."},{"key":"10.1016\/j.biochi.2023.03.013_bib16","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/sji.12329","article-title":"Clinical role of human leukocyte antigen in health and disease","volume":"82","author":"Mosaad","year":"2015","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.biochi.2023.03.013_bib17","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1038\/s41375-019-0490-0","article-title":"Chronic myeloid leukemia stem cells","volume":"33","author":"Houshmand","year":"2019","journal-title":"Leukemia"},{"key":"10.1016\/j.biochi.2023.03.013_bib18","doi-asserted-by":"crossref","DOI":"10.1002\/ajh.25792","article-title":"Chronic myeloid leukemia: 2020 update on diagnosis, therapy and monitoring","volume":"95","author":"Jabbour","year":"2020","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.biochi.2023.03.013_bib19","doi-asserted-by":"crossref","first-page":"4280","DOI":"10.1182\/bloodadvances.2019000865","article-title":"Managing chronic myeloid leukemia for treatment-free remission: a proposal from the GIMEMA CML WP","volume":"3","author":"Baccarani","year":"2019","journal-title":"Blood Adv."},{"key":"10.1016\/j.biochi.2023.03.013_bib20","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/imm.12675","article-title":"Antigen processing and immune regulation in the response to tumours","volume":"150","author":"Reeves","year":"2017","journal-title":"Immunology"},{"key":"10.1016\/j.biochi.2023.03.013_bib21","first-page":"999","article-title":"Defective HLA class I antigen processing machinery in cancer, Cancer Immunology","volume":"67","author":"Cai","year":"2018","journal-title":"Immunotherapy"},{"key":"10.1016\/j.biochi.2023.03.013_bib22","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.636568","article-title":"Cancer immune evasion through loss of MHC class I antigen presentation","volume":"12","author":"Dhatchinamoorthy","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biochi.2023.03.013_bib23","doi-asserted-by":"crossref","first-page":"S88","DOI":"10.1038\/sj.bmt.1702363","article-title":"Functional deficiencies of components of the MHC class I antigen pathway in human tumors of epithelial origin","volume":"25","author":"Delp","year":"2000","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.biochi.2023.03.013_bib24","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1002\/ijc.21163","article-title":"Total loss of MHC class I is an independent indicator of good prognosis in breast cancer","volume":"117","author":"Madjd","year":"2005","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.biochi.2023.03.013_bib25","first-page":"789","article-title":"Expression of antigen processing and presenting molecules in brain metastasis of breast cancer, cancer immunology","volume":"61","author":"Liu","year":"2012","journal-title":"Immunotherapy"},{"key":"10.1016\/j.biochi.2023.03.013_bib26","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1159\/000486585","article-title":"The role of immune escape and immune cell infiltration in breast cancer","volume":"13","author":"Steven","year":"2018","journal-title":"Breast Care"},{"key":"10.1016\/j.biochi.2023.03.013_bib27","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.3390\/cancers12071760","article-title":"MHC class I downregulation in cancer: underlying mechanisms and potential targets for cancer immunotherapy","volume":"12","author":"Cornel","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.biochi.2023.03.013_bib28","doi-asserted-by":"crossref","first-page":"7145","DOI":"10.1158\/0008-5472.CAN-10-1883","article-title":"The LMP7-K allele of the immunoproteasome exhibits reduced transcript stability and predicts High risk of colon cancer","volume":"71","author":"Fellerhoff","year":"2011","journal-title":"Cancer Res."},{"key":"10.1016\/j.biochi.2023.03.013_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2018\/8363265","article-title":"Total HLA class I antigen loss with the downregulation of antigen-processing machinery components in two newly established sarcomatoid hepatocellular carcinoma cell lines","volume":"2018","author":"Lei","year":"2018","journal-title":"J.\u00a0Immunol. Res."},{"key":"10.1016\/j.biochi.2023.03.013_bib30","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1158\/2159-8290.CD-17-0593","article-title":"Impaired HLA class I antigen processing and presentation as a mechanism of acquired resistance to immune checkpoint inhibitors in lung cancer","volume":"7","author":"Gettinger","year":"2017","journal-title":"Cancer Discov."},{"key":"10.1016\/j.biochi.2023.03.013_bib31","first-page":"8647","article-title":"Immune escape of melanoma: first evidence of structural alterations in two distinct components of the MHC class I antigen processing pathway","volume":"61","author":"Seliger","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/j.biochi.2023.03.013_bib32","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/1097-0215(20010120)95:1<23::AID-IJC1004>3.0.CO;2-4","article-title":"TAP1 down-regulation in primary melanoma lesions: an independent marker of poor prognosis","volume":"95","author":"Kamarashev","year":"2001","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.biochi.2023.03.013_bib33","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1002\/(SICI)1097-0215(19980209)75:4<590::AID-IJC16>3.0.CO;2-D","article-title":"Constitutive transduction of peptide transporter and HLA genes restores antigen processing function and cytotoxic T cell-mediated immune recognition of human melanoma cells","volume":"75","author":"White","year":"1998","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.biochi.2023.03.013_bib34","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.canlet.2004.11.064","article-title":"Mechanisms of immune evasion of human neuroblastoma","volume":"228","author":"Raffaghello","year":"2005","journal-title":"Cancer Lett."},{"key":"10.1016\/j.biochi.2023.03.013_bib35","first-page":"1721","article-title":"Characterization of human lymphocyte antigen class I antigen-processing machinery defects in renal cell carcinoma lesions with special emphasis on transporter-associated with antigen-processing down-regulation","volume":"9","author":"Seliger","year":"2003","journal-title":"Clin. Cancer Res.: Offi. J. Am. Ass. Cancer Res."},{"key":"10.1016\/j.biochi.2023.03.013_bib36","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/sj.leu.2404506","article-title":"Levels of soluble HLA-I and \u03b22M in patients with acute myeloid leukemia and advanced myelodysplastic syndrome: association with clinical behavior and outcome of induction therapy","volume":"21","author":"Albitar","year":"2007","journal-title":"Leukemia"},{"key":"10.1016\/j.biochi.2023.03.013_bib37","first-page":"147","article-title":"Serum beta-2 microglobulin levels are a significant prognostic factor in Philadelphia chromosome-positive chronic myelogenous leukemia","volume":"6","author":"Rodriguez","year":"2000","journal-title":"Clin. Cancer Res.: Offi. J. Am. Ass. Cancer Res."},{"key":"10.1016\/j.biochi.2023.03.013_bib38","first-page":"645","article-title":"Prognostic effect of beta 2-microglobulin in multiple myeloma","volume":"99","author":"Ortega","year":"1992","journal-title":"Med. Cl\u00ednica"},{"key":"10.1016\/j.biochi.2023.03.013_bib39","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1182\/blood-2002-10-3264","article-title":"Contribution of \u03b2-2 microglobulin levels to the prognostic stratification of survival in patients with myelodysplastic syndrome (MDS)","volume":"102","author":"Gatto","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.biochi.2023.03.013_bib40","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V122.21.4239.4239","article-title":"Serum beta-2 microglobulin level as a useful prognostic marker of hodgkin lymphoma","volume":"122","author":"Nakajima","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.biochi.2023.03.013_bib41","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1038\/leu.2008.391","article-title":"In situ analysis of the antigen-processing machinery in acute myeloid leukaemic blasts by tissue microarray","volume":"23","author":"Hoves","year":"2009","journal-title":"Leukemia"},{"key":"10.1016\/j.biochi.2023.03.013_bib42","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1182\/blood-2009-06-228676","article-title":"Alterations in the antigen processing-presenting machinery of transformed plasma cells are associated with reduced recognition by CD8+ T cells and characterize the progression of MGUS to multiple myeloma","volume":"115","author":"Racanelli","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.biochi.2023.03.013_bib43","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1111\/j.1471-4159.1985.tb07220.x","article-title":"Inactivation of neurotensin by rat brain synaptic membranes partly occurs through cleavage at the arg-8-arg-9 peptide bond by a metalloendopeptidase","volume":"45","author":"Checler","year":"1985","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.biochi.2023.03.013_bib44","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/j.1476-5381.1994.tb13041.x","article-title":"Role of endopeptidase 3.4.24.16 in the catabolism of neurotensin, in\u00a0vivo, in the vascularly perfused dog ileum","volume":"112","author":"Barelli","year":"1994","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.biochi.2023.03.013_bib45","doi-asserted-by":"crossref","first-page":"382","DOI":"10.3390\/biom9080382","article-title":"Thimet oligopeptidase (EC 3.4.24.15) key functions suggested by knockout mice phenotype characterization","volume":"9","author":"dos Santos","year":"2019","journal-title":"Biomolecules"},{"key":"10.1016\/j.biochi.2023.03.013_bib46","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S1074-7613(03)00058-X","article-title":"The cytosolic endopeptidase, thimet oligopeptidase, destroys antigenic peptides and limits the extent of MHC class I antigen presentation","volume":"18","author":"York","year":"2003","journal-title":"Immunity"},{"key":"10.1016\/j.biochi.2023.03.013_bib47","doi-asserted-by":"crossref","DOI":"10.3390\/biom10091229","article-title":"Thimet oligopeptidase biochemical and biological significances: past, present, and future directions","volume":"10","author":"Ferro","year":"2020","journal-title":"Biomolecules"},{"key":"10.1016\/j.biochi.2023.03.013_bib48","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/ni.1974","article-title":"Antigen processing by nardilysin and thimet oligopeptidase generates cytotoxic T cell epitopes","volume":"12","author":"Kessler","year":"2011","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.biochi.2023.03.013_bib49","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1093\/cvr\/cvt127","article-title":"Shear stress is a positive regulator of thimet oligopeptidase (EC3.4.24.15) in vascular endothelial cells: consequences for MHC1 levels","volume":"99","author":"Guinan","year":"2013","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.biochi.2023.03.013_bib50","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1002\/2211-5463.12245","article-title":"Redox modulation of thimet oligopeptidase activity by hydrogen peroxide","volume":"7","author":"Icimoto","year":"2017","journal-title":"FEBS Open Bio"},{"key":"10.1016\/j.biochi.2023.03.013_bib51","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1182\/blood.V45.3.321.321","article-title":"Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome","volume":"45","author":"Lozzio","year":"1975","journal-title":"Blood"},{"key":"10.1016\/j.biochi.2023.03.013_bib52","first-page":"63","article-title":"Multidrug resistance in leukemias: the problem and some approaches to its circumvention","volume":"46","author":"Rumjanek","year":"1994","journal-title":"Ciencia e Cult."},{"key":"10.1016\/j.biochi.2023.03.013_bib53","first-page":"694","article-title":"Differences in sensitivity to UVC, UVB and UVA radiation of a multidrug-resistant cell line overexpressing P-glycoprotein","volume":"69","author":"Trindade","year":"1999","journal-title":"Photochem. Photobiol."},{"key":"10.1016\/j.biochi.2023.03.013_bib54","doi-asserted-by":"crossref","first-page":"15410","DOI":"10.18632\/oncotarget.3795","article-title":"Inhibition of thioredoxin 1 leads to apoptosis in drug-resistant multiple myeloma","volume":"6","author":"Raninga","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.biochi.2023.03.013_bib55","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/cbin.10360","article-title":"K562 cells display different vulnerability to H2O2 induced oxidative stress in differing cell cycle phases","volume":"39","author":"Akcakaya","year":"2014","journal-title":"Cell Biol. Int."},{"key":"10.1016\/j.biochi.2023.03.013_bib56","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1373\/clinchem.2008.112797","article-title":"The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments","volume":"55","author":"Bustin","year":"2009","journal-title":"Clin. Chem."},{"key":"10.1016\/j.biochi.2023.03.013_bib57","doi-asserted-by":"crossref","first-page":"4417","DOI":"10.1021\/bi002715k","article-title":"Substrate specificity characterization of recombinant metallo oligo-peptidases thimet oligopeptidase and neurolysin","volume":"40","author":"Oliveira","year":"2001","journal-title":"Biochemistry"},{"key":"10.1016\/j.biochi.2023.03.013_bib58","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1161\/01.HYP.35.2.626","article-title":"A\u00a0novel stable inhibitor of endopeptidases EC 3.4.24.15 and 3.4.24.16 potentiates bradykinin-induced hypotension","volume":"35","author":"Smith","year":"2000","journal-title":"Hypertension"},{"key":"10.1016\/j.biochi.2023.03.013_bib60","doi-asserted-by":"crossref","first-page":"D624","DOI":"10.1093\/nar\/gkx1134","article-title":"The MEROPS database of proteolytic enzymes, their substrates and inhibitors in 2017 and a comparison with peptidases in the PANTHER database","volume":"46","author":"Rawlings","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.biochi.2023.03.013_bib61","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1111\/j.1471-4159.1985.tb07220.x","article-title":"Inactivation of neurotensin by rat brain synaptic membranes partly occurs through cleavage at the arg8-Arg9Peptide bond by a metalloendopeptidase","volume":"45","author":"Checler","year":"1985","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.biochi.2023.03.013_bib62","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1006\/bbrc.1999.0250","article-title":"Thimet oligopeptidase (EC 3.4.24.15), a novel protein on the route of MHC class I antigen presentation","volume":"255","author":"Silva","year":"1999","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.biochi.2023.03.013_bib63","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0106665","article-title":"Expression of THOP1 and its relationship to prognosis in non-small cell lung cancer","volume":"9","author":"Qi","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.biochi.2023.03.013_bib64","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1245\/s10434-014-3581-1","article-title":"Expression analysis of THOP1 in background liver, a prognostic predictive factor in hepatocellular carcinoma, extracted by multiarray analysis","volume":"21","author":"Nomoto","year":"2014","journal-title":"Ann. Surg Oncol."},{"key":"10.1016\/j.biochi.2023.03.013_bib65","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/1476-4598-6-44","article-title":"Characterization of thimet oligopeptidase and neurolysin activities in B16F10-Nex2 tumor cells and their involvement in angiogenesis and tumor growth","volume":"6","author":"Paschoalin","year":"2007","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.biochi.2023.03.013_bib66","series-title":"Extracellular Thimet Oligopeptidase Is Released with Extracellular Vesicles from Human Prostate Cancer Cells","author":"Liu","year":"2020"},{"key":"10.1016\/j.biochi.2023.03.013_bib67","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1096\/fasebj.3.14.2574119","article-title":"P-glycoprotein: multidrug-resistance and a superfamily of membrane-associated transport proteins","volume":"3","author":"Juranka","year":"1989","journal-title":"Faseb. J."},{"key":"10.1016\/j.biochi.2023.03.013_bib68","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1006\/scel.1993.1008","article-title":"P-glycoproteins: mediators of multidrug resistance","volume":"4","author":"Germann","year":"1993","journal-title":"Semin. Cell Biol."},{"key":"10.1016\/j.biochi.2023.03.013_bib69","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/0005-2736(76)90160-7","article-title":"A\u00a0surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants","volume":"455","author":"Juliano","year":"1976","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"10.1016\/j.biochi.2023.03.013_bib70","doi-asserted-by":"crossref","DOI":"10.4137\/DTI.S12519","article-title":"P-Glycoprotein inhibition for optimal drug delivery","volume":"7","author":"Amin","year":"2013","journal-title":"Drug Target Insights"},{"key":"10.1016\/j.biochi.2023.03.013_bib71","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1124\/dmd.113.056176","article-title":"Inhibition of the multidrug resistance P-glycoprotein: time for a change of strategy?","volume":"42","author":"Callaghan","year":"2014","journal-title":"Drug Metabol. Dispos."},{"key":"10.1016\/j.biochi.2023.03.013_bib72","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111632","article-title":"Phytochemicals reverse P-glycoprotein mediated multidrug resistance via signal transduction pathways","volume":"139","author":"Ganesan","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biochi.2023.03.013_bib73","article-title":"Associations of TAP1 genetic polymorphisms with atopic diseases: asthma, rhinitis and dermatitis","volume":"9","author":"Liu","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.biochi.2023.03.013_bib74","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2017.1356143","article-title":"TAP1 down-regulation elicits immune escape and poor prognosis in colorectal cancer","volume":"6","author":"Ling","year":"2017","journal-title":"OncoImmunology"},{"key":"10.1016\/j.biochi.2023.03.013_bib75","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1152\/physrev.00025.2001","article-title":"The transporter associated with antigen processing: function and implications in human diseases","volume":"82","author":"Lankat-Buttgereit","year":"2002","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.biochi.2023.03.013_bib76","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/351323a0","article-title":"Restored expression of major histocompatibility class I molecules by gene transfer of a putative peptide transporter","volume":"351","author":"Spies","year":"1991","journal-title":"Nature"},{"key":"10.1016\/j.biochi.2023.03.013_bib77","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/S0092-8674(05)80068-6","article-title":"TAP1 mutant mice are deficient in antigen presentation, surface class I molecules, and CD4\u22128+ T cells","volume":"71","author":"Kaer","year":"1992","journal-title":"Cell"},{"key":"10.1016\/j.biochi.2023.03.013_bib78","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.abb.2003.12.001","article-title":"Potential roles of protein oxidation and the immunoproteasome in MHC class I antigen presentation: the \u201cPrOxI\u201d hypothesis","volume":"423","author":"Teoh","year":"2004","journal-title":"Arch. Biochem. Biophys."}],"container-title":["Biochimie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300908423000755?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300908423000755?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T01:26:10Z","timestamp":1759541170000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0300908423000755"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":77,"alternative-id":["S0300908423000755"],"URL":"https:\/\/doi.org\/10.1016\/j.biochi.2023.03.013","relation":{},"ISSN":["0300-9084"],"issn-type":[{"value":"0300-9084","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Expression of thimet oligopeptidase (THOP) modulated by oxidative stress in human multidrug resistant (MDR) leukemia cells","name":"articletitle","label":"Article Title"},{"value":"Biochimie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biochi.2023.03.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. and Soci\u00e9t\u00e9 Fran\u00e7aise de Biochimie et Biologie Mol\u00e9culaire (SFBBM). All rights reserved.","name":"copyright","label":"Copyright"}]}}